Stockreport

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF - SAN711 is a first-in-class, highly selective GABAA-a3 positive allosteric modulator- Targeting initiation of Phase 2 study of SAN711 for the treatment of essential tre [Read more]